Loss of the oligosaccharyl transferase subunit TUSC3 promotes proliferation and migration of ovarian cancer cells

International Journal of Oncology

Volumn 42, Issue 4, 2013, Pages 1383-1389

  Vaňhara, Petr ^a   Horak, Peter ^b   Pils, Dietmar ^c   Anees, Mariam ^b   Petz, Michaela ^b   Gregor, Wolfgang ^d   Zeillinger, Robert ^c   Krainer, Michael ^b  

^a MASARYK UNIVERSITY   (Czech Republic)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

^d UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

Glycosylation; Ovarian cancer; Proliferation; TUSC3

Indexed keywords

ONCOPROTEIN; PROTEIN; STT3A PROTEIN; TUMOR SUPPRESSOR CANDIDATE 3 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BENIGN TUMOR; CANCER PATIENT; CANCER SURVIVAL; CARCINOMA CELL; CELL FRACTIONATION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; ENDOPLASMIC RETICULUM; EPIGENETICS; FEMALE; GENE EXPRESSION; GENE LOSS; GENE SILENCING; GLYCOSYLATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN LOCALIZATION;

CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; ENDOPLASMIC RETICULUM; FEMALE; GENE KNOCKDOWN TECHNIQUES; GLYCOSYLATION; HEXOSYLTRANSFERASES; HUMANS; MEMBRANE PROTEINS; OVARIAN NEOPLASMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN SUBUNITS; RNA, SMALL INTERFERING; TUMOR SUPPRESSOR PROTEINS;

EID: 84874640175     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.1824     Document Type: Article

References (30)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61:69-90, 2011.
2. Bova GS, MacGrogan D, Levy A, Pin SS, Bookstein R and Isaacs WB: Physical mapping of chromosome 8p22 markers and their homozygous deletion in a metastatic prostate cancer. Genomics 35:46-54, 1996.
3. MacGrogan D, Levy A, Bova GS, Isaacs WB and Bookstein R: Structure and methylation-associated silencing of a gene within a homozygously deleted region of human chromosome band 8p22. Genomics 35:55-65, 1996.
4. Bashyam MD, Bair R, Kim YH, et al: Array-based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer. Neoplasia 7:556-562, 2005.
5. Levy A, Dang UC and Bookstein R: High-density screen of human tumor cell lines for homozygous deletions of loci on chromosome arm 8p. Genes Chromosomes Cancer 24:42-47, 1999.
6. Arbieva ZH, Banerjee K, Kim SY, et al: High-resolution physical map and transcript identification of a prostate cancer deletion interval on 8p22. Genome Res 10:244-257, 2000.
7. Bova GS, Carter BS, Bussemakers MJ, et al: Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res 53:3869-3873, 1993.
8. Pils D, Horak P, Gleiss A, et al: Five genes from chromosomal band 8p22 are significantly down-regulated in ovarian carcinoma: N33 and EFA6R have a potential impact on overall survival. Cancer 104:2417-2429, 2005.
9. Pils D, Horak P, Vanhara P, et al: Methylation status of TUSC3 is a prognostic factor in ovarian cancer. Cancer Oct. 23, 2012 (Epub ahead of print). doi: 10.1002/cncr.27850.
10. Garshasbi M, Hadavi V, Habibi H, et al: A defect in the TUSC3 gene is associated with autosomal recessive mental retardation. Am J Hum Genet 82:1158-1164, 2008.
11. Molinari F, Foulquier F, Tarpey PS, et al: Oligosaccharyltransferase- subunit mutations in nonsyndromic mental retardation. Am J Hum Genet 82:1150-1157, 2008.
12. Zhou H and Clapham DE: Mammalian MagT1 and TUSC3 are required for cellular magnesium uptake and vertebrate embryonic development. Proc Natl Acad Sci USA 106:15750-15755, 2009.
13. Kelleher DJ and Gilmore R: An evolving view of the eukaryotic oligosaccharyltransferase. Glycobiology 16:R47-R62, 2006.
14. Kelleher DJ, Karaoglu D, Mandon EC and Gilmore R: Oligosaccharyltransferase isoforms that contain different catalytic STT3 subunits have distinct enzymatic properties. Mol Cell 12:101-111, 2003.
15. Schulz BL, Stirnimann CU, Grimshaw JP, et al: Oxidoreductase activity of oligosaccharyltransferase subunits Ost3p and Ost6p defines site-specific glycosylation efficiency. Proc Natl Acad Sci USA 106:11061-11066, 2009.
16. Collard JG, Schijven JF, Bikker A, La Riviere G, Bolscher JG and Roos E: Cell surface sialic acid and the invasive and metastatic potential of T-cell hybridomas. Cancer Res 46:3521-3527, 1986.
17. Dennis JW, Granovsky M and Warren CE: Glycoprotein glycosylation and cancer progression. Biochim Biophys Acta 1473:21-34, 1999.
18. Yogeeswaran G and Salk PL: Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines. Science 212:1514-1516, 1981.
19. Janik ME, Litynska A and Vereecken P: Cell migration-the role of integrin glycosylation. Biochim Biophys Acta 1800:545-555, 2010.
20. Kakugawa Y, Wada T, Yamaguchi K, et al: Up-regulation of plasma membrane-associated ganglioside sialidase (Neu3) in human colon cancer and its involvement in apoptosis suppression. Proc Natl Acad Sci USA 99:10718-10723, 2002.
21. Lau KS, Partridge EA, Grigorian A, et al: Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation. Cell 129:123-134, 2007.
22. Fang M, Shen Z, Huang S, et al: The ER UDPase ENTPD5 promotes protein N-glycosylation, the Warburg effect, and proliferation in the PTEN pathway. Cell 143:711-724, 2010.
23. Kuball J, Hauptrock B, Malina V, et al: Increasing functional avidity of TCR-redirected T cells by removing defined N-glycosylation sites in the TCR constant domain. J Exp Med 206:463-475, 2009.
24. Seales EC, Jurado GA, Singhal A and Bellis SL: Ras oncogene directs expression of a differentially sialylated, functionally altered beta1 integrin. Oncogene 22:7137-7145, 2003.
25. Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45, 2001.
26. Graham J and Rickwood D (eds): Subcellular fractionation, a practical approach. Oxford University Press, New York, 1997.
27. Karaoglu D, Kelleher DJ and Gilmore R: Functional characterization of Ost3p. Loss of the 34-kD subunit of the Saccharomyces cerevisiae oligosaccharyltransferase results in biased underglycosylation of acceptor substrates. J Cell Biol 130:567-577, 1995.
28. Hakomori S: Glycosylation defining cancer malignancy: new wine in an old bottle. Proc Natl Acad Sci USA 99:10231-10233, 2002.
29. Kobata A and Amano J: Altered glycosylation of proteins produced by malignant cells, and application for the diagnosis and immunotherapy of tumours. Immunol Cell Biol 83:429-439, 2005.
30. Saldova R, Dempsey E, Perez-Garay M, et al: 5-AZA-2'-deoxycytidine induced demethylation influences N-glycosylation of secreted glycoproteins in ovarian cancer. Epigenetics 6:1362-1372, 2011.